Caprock Group’s Pediatrix Medical MD Stock Holding History

Caprock Group’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$352K	Sell	13,902 -140	-1%	-$3.19K	0.01%	976
2026 Q1	$300K	Buy	+14,042	New	+$292K	0.01%	918

Other funds holding MD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Caprock Group's MD Position: Q2 2026 in Review

Caprock Group reduced its Pediatrix Medical (MD) stake by 1% in Q2 2026, selling an estimated $3.19K and leaving 13,902 shares worth $352K. The position accounts for 0.01% of the portfolio, ranked #976.

Caprock Group first reported a position in MD in Q1 2026 and has held it in 2 quarters since. 305 funds tracked by Wall St. Rank hold MD as of Q2 2026.

Caprock Group held 13,902 shares of Pediatrix Medical worth $352K as of Q2 2026.
Caprock Group sold 140 Pediatrix Medical shares in Q2 2026, an estimated $3.19K.
Pediatrix Medical made up 0.01% of Caprock Group's portfolio in Q2 2026, its #976 holding.
Caprock Group first reported a position in Pediatrix Medical in Q1 2026 and has held it in 2 quarters since.
305 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.